Results 211 to 220 of about 411,227 (332)

Antibody numbering schemes: advances, comparisons and tools for antibody engineering. [PDF]

open access: yesProtein Eng Des Sel
Zhu Z   +6 more
europepmc   +1 more source

Enhancing full-length antibody production by signal peptide engineering [PDF]

open access: gold, 2016
Yizhou Zhou   +7 more
openalex   +1 more source

Phenotypic plasticity in a novel set of EGFR tyrosine kinase inhibitor‐adapted non‐small cell lung cancer cell lines

open access: yesFEBS Open Bio, EarlyView.
Phenotypic plasticity in a newly established set of EGFR inhibitor‐adapted NSCLC cell lines during adaptation and in established cell lines. Here, we introduce novel sublines of the EGFR‐mutant non‐small cell lung cancer (NSCLC) cell lines HCC827 and HCC4006 adapted to the EGFR kinase inhibitors gefitinib (HCC827rGEFI2μm, HCC4006rGEFI1μm), erlotinib ...
Tharsagini V. Nanthaprakash   +6 more
wiley   +1 more source

Integrating Biochemical and Computational Approaches Reveal Structural Insights in Trastuzumab scFv-Fc Antibody Engineering. [PDF]

open access: yesBiomolecules
Bednova O   +9 more
europepmc   +1 more source

A Fast and Sensitive Luciferase-based Assay for Antibody Engineering and Design of Chimeric Antigen Receptors. [PDF]

open access: yesSci Rep, 2020
Natarajan V   +9 more
europepmc   +1 more source

The E3 ubiquitin ligase, RNF219, suppresses CNOT6L expression to exhibit antiproliferative activity

open access: yesFEBS Open Bio, EarlyView.
We identified RNF219 as a CCR4‐NOT complex‐interacting E3 ubiquitin ligase that targets the CCR4‐NOT subunit CNOT6L for ubiquitination. RNF219 directly binds to the DUF3819 domain of CNOT1 through its putative α‐helix spanning amino acids 521–542. Our findings also suggest that antiproliferative activity of RNF219 is at least partially mediated by ...
Shou Soeda   +9 more
wiley   +1 more source

Modelling the influence of foot-and-mouth disease vaccine antigen stability and dose on the bovine immune response [PDF]

open access: yes, 2011
Charleston, B   +7 more
core   +1 more source

Engineering the Human Fc Region Enables Direct Cell Killing by Cancer Glycan–Targeting Antibodies without the Need for Immune Effector Cells or Complement [PDF]

open access: bronze, 2020
Mireille Vankemmelbeke   +12 more
openalex   +1 more source

Home - About - Disclaimer - Privacy